Director Gautam Patel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director gautam patel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Gautam Patel Today - Breaking & Trending Today

Amneal Pharmaceuticals (NYSE:AMRX) Updates FY 2022 Earnings Guidance

Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided earnings per share guidance of $0.800-$0.850 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.900. The company issued revenue guidance of $2.15 billion-$2.25 billion, compared to the consensus revenue estimate of $2.17 […] ....

United States , Gautam Patel , Thomson Reuter , Chiragk Patel , Amneal Pharmaceuticals , Thomson Reuters , Securities Exchange Commission , Goldman Sachs Group Inc , Zacks Investment Research , Blackrock Inc , Deutsche Bank , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Company Profile Get Rating , Barclays Plc , Get Rating , Director Gautam Patel , Exchange Commission , Sachs Group , California State Teachers Retirement System , State Teachers Retirement System , Pharmaceuticals Company Profile , Nyse Amrx ,

Amneal Pharmaceuticals (NYSE:AMRX) Shares Down 8.1% After Earnings Miss

Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) traded down 8.1% during trading on Wednesday following a weaker than expected earnings announcement. The stock traded as low as $4.05 and last traded at $4.09. 2,359 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 491,801 shares. The stock had […] ....

Gautam Patel , Chiragk Patel , Amneal Pharmaceuticals , Asset Management Inc , Harel Insurance Investments Financial Services Ltd , Securities Exchange Commission , Zacks Investment Research , Man Group , Amneal Pharmaceuticals Inc , Lazard Asset Management , Covestor Ltd , Get Rating , Director Gautam Patel , Exchange Commission , Insurance Investments , Financial Services , Asset Management , Management Inc , Nyse Amrx ,

Amneal Pharmaceuticals (NYSE:AMRX) Issues FY 2022 Earnings Guidance

Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided EPS guidance of $0.800-$0.850 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.900. The company issued revenue guidance of $2.15 billion-$2.25 billion, compared to the consensus revenue estimate of $2.17 billion.Amneal Pharmaceuticals also updated […] ....

United States , Gautam Patel , Thomson Reuter , Chiragk Patel , Amneal Pharmaceuticals , Thomson Reuters , Securities Exchange Commission , Stifel Financial Corp , Zacks Investment Research , America Corp , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Company Profile Get Rating , Royal Bank , Get Rating , Director Gautam Patel , Exchange Commission , Financial Corp , Pharmaceuticals Company Profile , Nyse Amrx ,

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company reduced its holdings in shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) by 5.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,194 shares of the company’s stock after selling 3,125 shares during the period. The […] ....

United States , Gautam Patel , Chiragk Patel , Amneal Pharmaceuticals , Asset Management Inc , Harel Insurance Investments Financial Services Ltd , Securities Exchange Commission , Quarter For Amneal Pharmaceuticals , Zacks Investment Research , Manufacturers Life Insurance Company , Man Group , Amneal Pharmaceuticals Inc , Exchange Commission , Amneal Pharmaceuticals Profile Get Rating , Get Rating , Insurance Investments , Financial Services , Management Inc , Retirement System , Amalgamated Bank , Director Gautam Patel , Pharmaceuticals Profile , Nyse Amrx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,